U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H16N2O2S2
Molecular Weight 284.398
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EMERAMIDE

SMILES

SCCNC(=O)C1=CC(=CC=C1)C(=O)NCCS

InChI

InChIKey=JUTBAVRYDAKVGQ-UHFFFAOYSA-N
InChI=1S/C12H16N2O2S2/c15-11(13-4-6-17)9-2-1-3-10(8-9)12(16)14-5-7-18/h1-3,8,17-18H,4-7H2,(H,13,15)(H,14,16)

HIDE SMILES / InChI

Molecular Formula C12H16N2O2S2
Molecular Weight 284.398
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Emeramide or Irminix® (N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI)) is a lipid-soluble thiol-redox antioxidant and heavy metal chelator. Orphan Drug Designation has been granted for the prevention and treatment of mercury toxicity in the EU and USA. Phase 1 and Phase 2a clinical studies have been performed and found Irminix® to be effective and safe with no adverse effects. A Phase 2a clinical trial for the treatment of chronic obstructive pulmonary disease has been completed in summer of 2018 and found Irminix® to be safe with no adverse effects.

Approval Year

PubMed

PubMed

TitleDatePubMed

Sample Use Guides

For the 14 days of the intervention 100 mg NBMI, 300 mg NBMI or placebo were administered orally to all patients.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:11:22 UTC 2023
Edited
by admin
on Sat Dec 16 17:11:22 UTC 2023
Record UNII
4U7K5X4ANS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EMERAMIDE
INN   WHO-DD  
INN  
Official Name English
N,N'-BIS(2-MERCAPTOETHYL)ISOPHTHALAMIDE
Systematic Name English
NBMI
Common Name English
emeramide [INN]
Common Name English
1,3-BENZENEDICARBOXAMIDE, N1,N3-BIS(2-MERCAPTOETHYL)-
Systematic Name English
Emeramide [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 367312
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
EU-Orphan Drug EU/3/17/1864
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
Code System Code Type Description
WIKIPEDIA
BDTH2
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
DRUG BANK
DB12192
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
INN
9949
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
EPA CompTox
DTXSID10610932
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
CAS
351994-94-0
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
NCI_THESAURUS
C166785
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
SMS_ID
100000177193
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
FDA UNII
4U7K5X4ANS
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
PUBCHEM
21133161
Created by admin on Sat Dec 16 17:11:23 UTC 2023 , Edited by admin on Sat Dec 16 17:11:23 UTC 2023
PRIMARY
Related Record Type Details
INNOVATOR->PARENT
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY